Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase EARLY_PHASE1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Stomach Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Peritoneal Neoplasms 1Hyperthermia 1Gastrointestinal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 56Capecitabine 49Fluorouracil 37Cisplatin 37S 1 (combination) 23Paclitaxel 18Docetaxel 18Leucovorin 16pembrolizumab 13Irinotecan 12apatinib 11titanium silicide 9XELOX 9Trastuzumab 9Nivolumab 9Hyperthermic Intraperitoneal Chemotherapy 8Epirubicin 8Drug Therapy 8Tegafur 7Radiotherapy 6Neoadjuvant Therapy 6gimeracil 5Surgical Procedures, Operative 5Gastrectomy 5Chemotherapy, Adjuvant 5tislelizumab 4S-1 plus cisplatin 4Ramucirumab 4zolbetuximab 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Stomach Neoplasms × Cytoreduction Surgical Procedures × Clear all
NCT03348150 2025-07-17

PERISCOPEII

The Netherlands Cancer Institute

Phase 3 Active not recruiting
102 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03023436 2019-09-13

Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
220 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡